Nerve Renew Reviews: What Changed in the 2026 Formula, and Does It Match the Research?

Nerve Health · Neuropathy Supplement Reviews

For fifteen years the formula didn't change. In 2026 it changed almost completely, and half the reviews online still describe the old bottle.

If you are reading Nerve Renew reviews right now, there is a good chance the review in front of you is describing a product that no longer exists.

This review is written for adults dealing with nerve discomfort or early neuropathy, especially readers over 40 who want transparent dosing rather than a proprietary blend. In 2026, Nerve Renew made the first change to its formula since 2010, and it was not a tweak. Two ingredients were added, two were cut, the herbal blend and several minor vitamins were removed, and the daily serving doubled from two capsules to four.

Most pages online have not caught up. Ingredient guides, pharmacist reviews and retailer listings still show the original 300 mg R-lipoic acid formula, so searchers get two different ingredient lists for one product name. Both are real. They are just different bottles.

Here is the short version of what I found: the new formula is a well-designed, fully disclosed label built around studied doses, and in structure it is now closer to my own formula than any product I have reviewed. A fair review says that plainly. A fair review also checks the brand's own explanations against the studies it cites, and in one place, the benfotiamine cut, the explanation and the study don't line up.

That is the same question I asked of every technique I adopted over more than 20 years as a peripheral nerve surgeon: what was tested, at what dose, in whom, and does this match it?

A disclosure before we start. I formulated NeuroAxis, a nerve support supplement sold on this site, and I authored the two published clinical studies on its predecessor formula. That is a conflict of interest, and you should weigh it. It is also why every statement about Nerve Renew below comes from its own website, a retailer listing or a published study, with the date I checked it, and why NeuroAxis appears later against the same yardstick, including where Nerve Renew has something mine does not and where mine costs more.

Old vs New Nerve Renew: Which Bottle Do You Have?

Nerve Renew has been sold since 2010 at nerverenew.com and through retailers. The brand's own upgrade page calls the 2026 change its biggest in 15 years and publishes a side-by-side table. Here it is, with the original formula's minor ingredients filled in from independent label records.

New-formula figures and the brand's change labels from nerverenew.com (product page and "upgraded formula" page), reviewed October 26, 2026. Original-formula minor ingredients cross-checked against HelloPharmacist (label dated December 13, 2022) and Innerbody.

How to Tell Which Nerve Renew You Are Holding

Three checks settle it in under a minute:

Capsules per day. The new formula says four capsules daily, two before breakfast and two before dinner. The original says two.

The alpha-lipoic acid line. The new formula lists 600 mg of alpha-lipoic acid. The original lists 300 mg of R-alpha-lipoic acid (R-ALA).

A herbal blend. If the panel lists feverfew, oat straw, passionflower and skullcap, it is the original.

This matters most if you buy outside the brand's own site. On October 26, 2026, the Amazon listing for Nerve Renew Advanced Nerve Support still carried the original formula's title, describing 300 mg stabilized R-alpha lipoic acid, vitamin B complex, benfotiamine and herbs in a 60-count bottle. The brand's own product page metadata also still mentions R-alpha lipoic acid. Neither is wrong to exist. The brand says it is keeping "legacy inventory" of the original on hand, and existing subscribers are switched to the new formula automatically at the same price unless they ask to stay on the original. It just means two people can both be "taking Nerve Renew" and be taking very different doses. The brand names Dr. Don Kennedy as its chief medical advisor.

One more naming note. Among its other Nerve Renew products, the brand sells a separate one called Nerve Renew Optimizer, listed on Amazon at 300 mg of stabilized R-alpha-lipoic acid per capsule. If you take Optimizer alongside the new formula, your alpha-lipoic acid adds up, so count it.

Nerve Renew Ingredients, One by One vs the Research

Nerve Renew's 2026 pages make a specific promise: every dose was tuned to a level used in published human research. That is a testable claim, and to the brand's credit it names the studies, so each one can be checked. Here is the yardstick.

Two doses went up, two came down, and two ingredients are new. Every new dose has a published study behind it.

Alpha-Lipoic Acid, 600 mg: A Sound Change

Alpha-lipoic acid (ALA) is an antioxidant that works in both the watery and the fatty compartments of a cell. That matters for nerves, whose membranes and myelin (the fatty insulation around many nerve fibers) are rich in fat. It also helps regenerate the cell's own antioxidants, including glutathione, and it targets the oxidative stress (damage from reactive oxygen molecules) that high blood sugar generates inside nerve tissue.

In the SYDNEY 2 trial, Ziegler and colleagues gave 181 people with diabetic neuropathy 600, 1,200 or 1,800 mg of ALA by mouth once a day for five weeks. Total symptom scores, which combine stabbing pain, burning, pins and needles and numbness in the feet, fell by 51% at 600 mg compared with 32% on placebo. The higher doses added side effects without adding benefit. Nerve Renew quotes the same 51% vs 32% figure, and it matches the published trial.

The R vs racemic question. ALA comes in two mirror-image forms, R and S. The R form is the one the body makes and uses in its own enzymes. Most supplements, and the major trials, use racemic ALA, a 50/50 mix of the two. The original Nerve Renew used 300 mg of R-ALA. The new formula uses 600 mg of racemic ALA, and the brand points out that 600 mg racemic contains about 300 mg of the R form. That arithmetic is correct. So in R-form content the two formulas are roughly equal, and the new one now matches the form and amount the trials actually used.

The R form alone, or the 50/50 mix the trials used: 600 mg of racemic ALA carries about 300 mg of the R form.

In fairness, I should say where my own formula sits. NeuroAxis uses 600 mg of R-ALA. The R form has better-characterized activity in lab and absorption studies, but no neuropathy trial has shown R-ALA beats racemic ALA for symptoms. The trials used racemic. So I would not tell you either choice is proven superior. Matching the trial form, as Nerve Renew now does, is a defensible decision. My alpha-lipoic acid for neuropathy review covers the full evidence, including the longer trials where results are weaker.

PEA, 600 mg: A Real Addition, With Context

Palmitoylethanolamide (PEA) is a fat-derived signaling molecule the body makes on its own. It works on a different pathway from everything else in this formula: it helps calm overactive immune cells, particularly mast cells and microglia, that amplify pain signaling around injured nerves. In the operating room I saw how much of a nerve's trouble came from its environment rather than the nerve fibers themselves, and PEA is aimed at exactly that environment.

The trial Nerve Renew points to is real and well designed. Pickering and colleagues (2022) ran a single-center, quadruple-blinded, placebo-controlled trial in 70 people with diabetic peripheral neuropathic pain. Participants took 600 mg of PEA or placebo daily for eight weeks. The PEA group had significant reductions in total pain and pain interference, improved sleep scores and lower depression scores, and it was well tolerated, with no changes in safety blood tests.

Three pieces of context belong next to that result. It is one trial, it lasted eight weeks, and it studied diabetic nerve pain specifically. And the formulation matters. The trial used a branded PEA combined with a dispersion technology designed to improve absorption (Levagen+, according to the full paper). Nerve Renew uses "micronized" PEA, a different approach to the same absorption problem, and does not name a branded form. Because PEA is poorly soluble and absorption depends heavily on how it is processed, I can't confirm that Nerve Renew's PEA behaves like the one studied. That is not a criticism of the choice; it is a gap the brand could close by naming its source.

NeuroAxis does not contain PEA. That is a genuine point in Nerve Renew's favor in any side-by-side comparison, and I come back to it below.

Acetyl-L-Carnitine, 500 mg: Reasonable, at the Low End

Acetyl-L-carnitine (ALCAR) helps shuttle fatty acids into mitochondria, the energy plants inside cells. That matters for peripheral nerves because the longest axons in the body run from the spinal cord to the toes, and every inch of them needs fuel.

Nerve Renew cites a meta-analysis of four randomized trials with 523 patients. That matches Li and colleagues (2015), which pooled placebo-controlled ALCAR trials in diabetic neuropathy and HIV treatment-related neuropathy and found a moderate reduction in pain scores. The citation is accurate.

The dose is where it gets thinner. A 2019 Cochrane review found that the placebo-controlled trials used 1,500 to 3,000 mg a day. In its subgroup analysis, doses of 1,500 mg or less were little different from placebo, while doses above 1,500 mg reduced pain more, and it rated the overall evidence as very low certainty. At 500 mg, Nerve Renew provides a third of the lowest dose those trials tested.

I hold my own formula to the same standard: NeuroAxis has 600 mg of ALCAR, also well below the trial range. In both products, ALCAR is better described as supporting the energy pathway than as a trial-dose ingredient.

The Benfotiamine Question: What BENDIP Actually Found

Benfotiamine is a fat-soluble form of vitamin B1 that reaches tissue levels plain thiamine cannot. Active thiamine switches on an enzyme called transketolase, which diverts damaging sugar byproducts away from the pathways that injure nerves when blood glucose runs high.

The original Nerve Renew had 600 mg of benfotiamine. The new formula has 300 mg, and the brand explains the change by citing the BENDIP trial (Stracke 2008). Its upgrade page says that 300 mg improved neuropathy symptom scores against placebo over six weeks, and that the larger daily amount did not deliver a meaningfully better result.

Here is what the BENDIP abstract reports. The trial randomized 165 people with diabetic polyneuropathy to 600 mg benfotiamine, 300 mg benfotiamine or placebo for six weeks. The primary outcome, the Neuropathy Symptom Score, differed significantly between groups in the per-protocol analysis (p = 0.033) and fell just short of significance in the intention-to-treat analysis (p = 0.055). And the authors' own summary states: "The improvement was more pronounced at the higher benfotiamine dose."

So BENDIP's own conclusion was that the 600 mg arm did somewhat better. The abstract does not report a formal statistical test between the two doses, so whether the difference was "meaningful" is a judgment call. But the study's summary leans toward the higher dose, not away from it.

That does not make 300 mg a bad choice. 300 mg is a studied dose, it is the lower of BENDIP's two arms, and it is exactly what NeuroAxis uses too. Fitting 600 mg of PEA and 500 mg of ALCAR into four capsules involves trade-offs, and lowering benfotiamine is a reasonable one to make. The point is narrower: if you are choosing between the old and new Nerve Renew partly on benfotiamine, the trial the brand cites gives the edge to the old formula's dose. My benfotiamine and B vitamins review covers the rest of that evidence.

Methylcobalamin, 1,000 mcg: Supported, With a Caveat About Who Was Studied

Methylcobalamin is the active coenzyme form of vitamin B12. B12 is essential for building and maintaining myelin, and deficiency is one of the most common correctable causes of neuropathy I saw.

Nerve Renew cut B12 from 4,000 mcg to 1,000 mcg. The study behind the new dose is solid. In a one-year, double-blind, placebo-controlled trial, Didangelos and colleagues (2021) gave 1,000 mcg of oral methylcobalamin daily to people with type 2 diabetes and diabetic neuropathy. Over 12 months, B12 levels rose and the treated group improved in vibration perception, nerve conduction, pain scores and quality of life, while the placebo group declined on several measures.

The caveat is who was in it. Every participant had been on metformin for at least four years and had B12 levels below 400 pmol/L, which is low-normal to low. Metformin is well known to reduce B12 absorption over time. So this trial shows that 1,000 mcg helps people whose B12 is running low. It does not tell us whether people with normal B12 would benefit at all. If you take metformin or acid-suppressing medication, ask your doctor for a B12 level, ideally with methylmalonic acid, before relying on any supplement. My review of why B12 isn't always helping neuropathy explains how to read those results.

The brand's other reason for the cut, that B12 absorption is saturable, is reasonable as a general statement. The main absorption pathway through intrinsic factor (a protein made in the stomach) saturates at a few micrograms per meal, and above that the body absorbs only about 1% of an oral dose by passive diffusion. That is exactly why oral doses in the hundreds or thousands of micrograms work at all. For context, the neuropathy trials pooled in a 2020 meta-analysis most often used about 1,500 mcg a day, and NeuroAxis uses 2,000 mcg. 1,000 mcg sits at the low end of the studied range, matched to one good trial. My methylcobalamin guide covers the rest.

Removing the Herbal Blend and Minor Vitamins: Better Transparency

The original formula's 84 mg herbal blend split four herbs across one combined weight, which left each at a small, undisclosed dose with no neuropathy research behind it. Removing it is a clear improvement in transparency. So is removing the minor vitamins, which the brand describes as below the levels used in nerve research.

Dropping B6 has one more benefit. Chronic high intake of vitamin B6 can itself cause a sensory neuropathy, and the risk is cumulative across everything you take. The original's 8 mg was modest, but the new formula's zero means one less source to add up. My review of vitamin B6 and peripheral neuropathy covers the thresholds.

Does Nerve Renew Work?

There are two different questions inside that one, and they have different answers.

Do the ingredients have evidence at these doses? Mostly yes. Alpha-lipoic acid, PEA, benfotiamine and methylcobalamin are each at a dose that improved something in a published human trial. Acetyl-L-carnitine is below its trial range.

Has the finished product been tested? No. The brand markets Nerve Renew to support healthy nerve function, but I found no published clinical research on Nerve Renew itself, old or new, and the brand says so plainly on its upgrade page, describing its research as studies of individual ingredients rather than trials of the finished product. That candor deserves credit. Plenty of brands in this category imply otherwise.

Who the Trials Studied

Look at the populations behind the five key ingredients and a pattern appears: almost all of them studied diabetic neuropathy. SYDNEY 2, Pickering, BENDIP and Didangelos all enrolled people with diabetes. The ALCAR meta-analysis added people with HIV treatment-related neuropathy. If your neuropathy comes from chemotherapy, a vitamin deficiency, alcohol, an autoimmune process or no identified cause at all, these results are a reasonable starting assumption, not a demonstrated fact.

Do Combinations Beat Single Ingredients?

Nerve Renew's "Five Pathways" framing rests on an idea I share: neuropathy develops along several pathways at once, so a formula that addresses several of them should do more than any one ingredient. The research trend supports that direction. In an eight-week study by Popa and colleagues (2019), people with diabetic neuropathy taking alpha-lipoic acid together with benfotiamine were far more likely to see symptoms cut in half (65%) than those taking either alone (28% and 11%). A six-month randomized, placebo-controlled trial by Didangelos and colleagues (2024) tested a multi-ingredient formula that included alpha-lipoic acid, B vitamins and PEA, and found improvements in pain and vibration sense the placebo group did not show.

Two honest qualifiers. The Popa study was small and unblinded, and its benefit faded within 12 weeks of stopping. And most combination trials compare a formula with placebo, not with its own ingredients, so they show combinations can work without proving the combination beats each part. No finished formula, Nerve Renew and NeuroAxis included, has been tested against its own ingredients.

How Long Before You Would Notice Anything?

The trials ran from five weeks (ALA) to eight weeks (PEA) to six weeks (benfotiamine) to a full year (B12). The brand's own guidance is longer: it says many people give the formula four to six months before judging it, and its guarantee runs 365 days. That longer window is consistent with nerve biology. Symptom changes from antioxidant and anti-inflammatory effects can come within weeks, but actual nerve regrowth proceeds at roughly a millimeter a day, so structural recovery in the feet takes months at best. My guide to how long nerve supplements take to work breaks this down ingredient by ingredient.

Nerve Renew Side Effects

Most people searching "Nerve Renew side effects" are really asking about the ingredients. For most adults the risk is low, and the most common complaint is stomach upset. These are the points worth knowing.

Alpha-lipoic acid: stomach upset and low blood sugar. Nausea, heartburn and stomach upset are the most common complaints with ALA, and taking it on an empty stomach, as Nerve Renew's directions advise, makes them more likely for some people. ALA can lower blood glucose, so if you take insulin or a sulfonylurea, talk with your doctor and monitor more closely when you start. If you take thyroid medication, ask your doctor before starting ALA, and keep the timing of your thyroid dose consistent. A rare autoimmune form of low blood sugar has been reported with ALA, mostly in people with a specific genetic background.

Acetyl-L-carnitine: stomach upset and restlessness. In the trials, the most common problems were gastrointestinal symptoms and headache. Some people find ALCAR stimulating, which is one reason not to take it late in the evening.

PEA: generally well tolerated. In the Pickering trial, PEA at 600 mg a day caused no changes in safety blood tests and was well tolerated over eight weeks.

Benfotiamine and methylcobalamin have good safety records in trials and are generally well tolerated, but review other supplements as well so you do not stack overlapping vitamins without realizing it.

Pregnancy and breastfeeding: these ingredients have not been studied for this use in pregnancy or breastfeeding, so talk with your obstetrician first.

Kidney disease or dialysis: I am not aware of trials of these ingredients at these doses in people with reduced kidney function. That is a gap in the evidence, not a finding of harm. Review any supplement with your nephrologist before you start, and bring the label.

Prescription medications: talk to your prescriber before combining Nerve Renew with any prescription medication, and never stop or change a prescription on your own because you started a supplement. Some testimonials for supplements in this category describe people coming off their medications. That decision belongs with your prescriber, every time.

The larger risk is not on any label. It is the opportunity cost: months on any supplement while an untreated B12 deficiency, a rising A1C or a compressed nerve keeps doing damage.

Nerve Renew Dosage: How to Take It

New formula: four capsules a day. The brand recommends two about an hour before breakfast and two about an hour before dinner. One 120-capsule bottle is a 30-day supply.

Original formula: two capsules a day, 60 per bottle.

Four capsules a day, split before breakfast and before dinner.

The before-meal timing makes sense for alpha-lipoic acid, whose absorption is reduced by food, which is why many ALA products advise an empty stomach. If that upsets your stomach, raise it with your pharmacist rather than simply doubling up later in the day. Do not double up after a missed dose.

Four capsules a day is a real commitment, twice the original's pill count. The most common reason any supplement fails is that people stop taking it, so be honest with yourself about whether a twice-daily, before-meal daily routine will last the four to six months the brand itself recommends.

Nerve Renew Price: Website vs Amazon vs Walmart

Here is what each channel charged on October 26, 2026. Note the formula column. A cheaper listing may be a different product.

The Amazon bottle is cheaper because it is a different formula. On October 26, 2026, the Nerve Renew Advanced Nerve Support listing on Amazon was the original two-capsule formula, 60 capsules for $39.99. If you want the 2026 formula, that listing is not it, whatever the price. On the brand site, one bottle of the new formula is a full month. Amazon also carried Nerve Renew Optimizer (300 mg R-ALA, 30 capsules) at $33.00 and a Nerve Relief Cream, both separate products.

The brand's site says subscriptions save up to 38% and ship free, and can be paused or canceled at any time. Launch offers on the upgrade page, including a four-bottle bundle, were marked as ended when I checked, so I have not quoted them.

The guarantee. Nerve Renew offers a 365-day money-back guarantee, a full year, and the brand describes it as no-questions-asked. The upgrade page also says the refund covers your most recent order. That is a common structure and a generous window, but if you buy several months at a time, it is worth knowing what "most recent order" will mean for you before you start. Retailer purchases follow the retailer's own return policy.

Nerve Renew Reviews and Complaints: How to Read Them

Nerve Renew reports a 4.4-star rating on Yotpo, 4.1 on Trustpilot, 4.1 on Google and an A+ from the Better Business Bureau, as displayed on its own site on October 26, 2026. Those are the brand's figures, and they reflect fifteen years of customers. On Amazon, the original-formula listing showed 3.9 stars from about 3,500 ratings on the same date.

Those fifteen years are the point that matters most right now. Nearly all of those reviews, written over several years, describe the original formula. The new formula launched in 2026, so a review from 2022 tells you how people felt about 300 mg of R-ALA, high-dose B vitamins and an herbal blend, not about PEA and acetyl-L-carnitine. When you read Nerve Renew reviews, check the date first, and give the latest reviews more weight.

Then look for what a star rating can't show: the reviewer's dose, how long they took it, whether they changed their diet, medications or activity at the same time, and what kind of neuropathy those consumers describe. Individual results vary, and testimonials on any brand's site, this one included, are selected by the brand.

On complaints, the patterns worth checking with any supplement company apply here too: how easily you can cancel a subscription, whether the guarantee covers what you expect, and whether the product you received matches the label you read. If you have a specific problem, the brand lists support@nerverenew.com.

How Nerve Renew Compares to Other Nerve Supplements

Against the other products in my neuropathy supplement reviews, the 2026 Nerve Renew formula lands near the top on dose and transparency, and it is the only one of them with PEA at the studied dose.

Comparison figures from my label reviews of each product, October 2026. Check each current label before buying.

If you are weighing several products, my guide to how to choose a nerve health supplement walks through the checklist step by step.

The Bigger Question: What Is Driving Your Symptoms?

No label review answers the most important question, which is why your nerves are misbehaving in the first place. Peripheral neuropathy has well over a hundred causes, including diabetes and prediabetes, B12 and other vitamin deficiencies, thyroid disease, alcohol, chemotherapy, medications and nerve compression. Many of those need cause-specific treatment that no supplement provides, and while supplements may support symptoms or general nerve health, they are not proven to reverse established nerve damage.

If you are not sure what is driving your symptoms, or whether a supplement makes sense for your situation at all, you can book a free 10-minute nerve health discovery call and talk it through with me directly. Sorting out the likely driver first is how you avoid spending months on the wrong solution.

Symptoms in one hand or one foot rather than both, weakness, or rapid progression are reasons to be evaluated promptly. Numbness and tingling in the thumb, index and middle fingers that wakes you at night is the classic pattern of carpal tunnel syndrome, a mechanical compression no capsule can decompress.

If you are not sure which tests to ask for, start with which test detects neuropathy. If your blood sugar has been creeping up, read how high blood sugar damages nerves, because glucose control does more for diabetic nerves than any capsule on this page.

If You Are Taking or Considering Nerve Renew: A Timeline

Where NeuroAxis Lands on the Same Yardstick

Since I put my own product in those tables, here are its numbers and its trade-offs, held to the same standard.

NeuroAxis daily dose (6 tablets): R-alpha-lipoic acid 600 mg, methylcobalamin 2,000 mcg, benfotiamine 300 mg, vitamin B6 10 mg (pyridoxine HCl), acetyl-L-carnitine 600 mg, N-acetyl cysteine 900 mg, CoQ10 150 mg, curcumin 500 mg with BioPerine 10 mg, vitamin D3 800 IU, bromelain 600 GDU and serrapeptase 40,000 SU. Every amount is disclosed.

What the two formulas share. Both have 600 mg of alpha-lipoic acid, 300 mg of benfotiamine and acetyl-L-carnitine below the trial range. Both disclose every dose. Both are built on the idea that neuropathy needs more than one pathway addressed. In design, the 2026 Nerve Renew is closer to NeuroAxis than anything else I have reviewed.

What Nerve Renew has that NeuroAxis does not: PEA at 600 mg, the dose from a randomized trial in diabetic nerve pain. It also costs less on subscription: about $1.44 to $1.63 a day, against about $2.00 a day for NeuroAxis ($59.99 a month on subscription, with free shipping). And it is four capsules a day rather than six tablets.

What NeuroAxis has that Nerve Renew does not: R-ALA rather than racemic (not proven better in trials, as I said above), twice the methylcobalamin, N-acetyl cysteine (a precursor to glutathione, the nerve cell's main internal antioxidant), CoQ10 for mitochondrial energy, curcumin with BioPerine, bromelain and serrapeptase for the inflammatory and tissue environment around the nerve, a modest 10 mg of B6 and 800 IU of vitamin D3. Where NeuroAxis falls short: ALCAR at 600 mg and CoQ10 at 150 mg are both below their trial doses.

The bigger difference is the program. I treat any nerve support supplement, including my own, as the third and smallest of three pillars, after nutrition and lifestyle. The reason is the evidence. The human study that actually increased nerve fiber density, a lifestyle intervention trial in people with prediabetic neuropathy (Smith, 2006), used diet and exercise, not pills. That is why every NeuroAxis order includes the 160-page NeuroAxis Protocol, my guide to the nutrition and lifestyle work that comes first. My own clinical studies were on the predecessor formula in carpal tunnel surgery patients, not neuropathy, and I take them apart honestly in my NeuroAxis review.

That Protocol turns a bottle into a plan:

Pillar 1, Nutrition: how to eat to stabilize blood sugar and reduce the metabolic stress that drives most neuropathy, including the nutrients, such as magnesium, that are better covered by diet than by another capsule.

Pillar 2, Lifestyle: exercise, sleep and daily habits, the interventions with the strongest human evidence for nerve fiber regrowth.

Pillar 3, Targeted nutrients: where NeuroAxis fits, how to take it, and how to track whether it is helping.

So the choice comes down to this. If you want PEA at the studied dose and a lower subscription price, the 2026 Nerve Renew formula delivers both. If you want the core three at trial doses, broader pathway coverage and a step-by-step plan for the nutrition and lifestyle work that does the heaviest lifting, that is what NeuroAxis and the NeuroAxis Protocol are built for. And if you are not sure which fits, book a free 10-minute discovery call and I will tell you honestly.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. I formulated NeuroAxis and have a financial interest in it.

Frequently Asked Questions

Does Nerve Renew really work?

No published trial has tested Nerve Renew itself, and the brand says so. The 2026 formula's ingredients each have human evidence at or near these doses: 600 mg alpha-lipoic acid (SYDNEY 2), 600 mg PEA (Pickering 2022), 300 mg benfotiamine (BENDIP) and 1,000 mcg methylcobalamin (Didangelos 2021). Acetyl-L-carnitine at 500 mg is below the trial range. Most of the trials studied people with diabetic neuropathy.

What are the ingredients in Nerve Renew?

The 2026 formula, per four-capsule daily serving: alpha-lipoic acid 600 mg, micronized PEA 600 mg, acetyl-L-carnitine 500 mg, benfotiamine 300 mg and methylcobalamin 1,000 mcg. The original formula, per two capsules, had 300 mg R-alpha-lipoic acid, 600 mg benfotiamine, 4,000 mcg methylcobalamin, several minor vitamins including B6, and an 84 mg blend of herbal extracts.

What changed in the new Nerve Renew formula?

Alpha-lipoic acid went from 300 mg of R-ALA to 600 mg of racemic ALA. PEA (600 mg) and acetyl-L-carnitine (500 mg) were added. Benfotiamine dropped from 600 mg to 300 mg and methylcobalamin from 4,000 mcg to 1,000 mcg. The herbal blend and four minor vitamins were removed, and the daily serving went from two capsules to four.

Is the Nerve Renew at Walmart or Amazon the new formula?

Not necessarily. On October 26, 2026, the Amazon listing was the original formula: 300 mg R-alpha-lipoic acid in a 60-count bottle for $39.99. Check the label: four capsules a day and 600 mg alpha-lipoic acid means the new formula; two capsules a day, 300 mg R-ALA and an herbal blend mean the original.

Why did Nerve Renew lower the benfotiamine and B12?

The brand says it matched each dose to published research. 1,000 mcg methylcobalamin matches a one-year trial in people on metformin with low B12. For benfotiamine, the brand says the higher dose in the BENDIP trial was not meaningfully better, but BENDIP's own summary says improvement was more pronounced at 600 mg. Both 300 and 600 mg were studied.

Does Nerve Renew still have R-lipoic acid?

The 2026 formula uses 600 mg of racemic alpha-lipoic acid, a 50/50 mix of the R and S forms, which provides about 300 mg of the R form. The original used 300 mg of stabilized R-ALA. The brand's separate Nerve Renew Optimizer product is listed with R-alpha-lipoic acid. No neuropathy trial has shown R-ALA works better than racemic ALA.

How many Nerve Renew capsules should I take a day?

The 2026 formula is four capsules daily: two about an hour before breakfast and two about an hour before dinner. The original formula was two capsules daily. Do not double up after a missed dose, and talk with your pharmacist if the empty-stomach timing upsets your stomach.

What are the side effects of Nerve Renew?

Most people tolerate the ingredients well. Alpha-lipoic acid can cause nausea, heartburn and stomach upset, can lower blood sugar (important with insulin or sulfonylureas) and warrants a doctor's input if you take thyroid medication. Acetyl-L-carnitine can cause stomach upset and restlessness. PEA was well tolerated in its trial.

Can I take Nerve Renew with gabapentin?

Gabapentin is a prescription medication for neuropathic pain, and Nerve Renew is a dietary supplement. Talk to your prescriber before combining them or changing anything, and bring the label so they can see the exact amounts. Never stop, reduce or replace gabapentin with a supplement on your own.

How long does Nerve Renew take to work?

The brand says many people give it four to six months before judging it. The ingredient trials measured changes over five weeks to one year. Symptom changes can come within weeks, but nerve regrowth proceeds at about a millimeter a day, so structural recovery takes months.

How much does Nerve Renew cost?

On October 26, 2026, nerverenew.com charged $69 for a one-time 30-day supply ($2.30 a day), $48.99 a month on subscription ($1.63 a day) and $129.95 for a three-month subscription ($1.44 a day). Amazon listed the original formula at $39.99 for 60 capsules ($1.33 a day). Check which formula a retailer is selling before comparing prices.

Does Nerve Renew have a 1 year money back guarantee?

Yes. The brand offers a 365-day money-back guarantee and says it refunds your most recent order. Purchases from retailers such as Amazon or Walmart follow the retailer's return policy.

Nerve Renew vs NeuroAxis: what is the difference?

Both have 600 mg alpha-lipoic acid and 300 mg benfotiamine and disclose every dose. The 2026 Nerve Renew adds 600 mg PEA, has 1,000 mcg methylcobalamin and costs about $1.44 to $2.30 a day. NeuroAxis, which I formulated, has 2,000 mcg methylcobalamin, NAC, 600 mg acetyl-L-carnitine, CoQ10, curcumin, bromelain and serrapeptase, and every order includes the 160-page NeuroAxis Protocol for nutrition, exercise, sleep and progress tracking. It costs about $2.00 a day on subscription.

Sources (Reviewed October 26, 2026)

Nerve Renew: nerverenew.com/products/nerve-renew-advanced-nerve-support and nerverenew.com/pages/nerve-renew-upgraded-formula, reviewed October 26, 2026. Original formula: HelloPharmacist (label dated December 13, 2022) and Innerbody. Amazon listing ASIN B01N28AC6V (title, price and rating reviewed October 26, 2026). Walmart: no Nerve Renew-brand listing found, October 26, 2026.

Studies: Ziegler D, et al. SYDNEY 2. Diabetes Care 2006 (doi:10.2337/dc06-1216). Pickering E, et al. Inflammopharmacology 2022 (doi:10.1007/s10787-022-01033-8). Stracke H, et al. BENDIP. Exp Clin Endocrinol Diabetes 2008 (doi:10.1055/s-2008-1065351). Didangelos T, et al. Nutrients 2021 (doi:10.3390/nu13020395). Li S, et al. PLoS One 2015 (doi:10.1371/journal.pone.0119479). Rolim LC, et al. Cochrane Database Syst Rev 2019 (doi:10.1002/14651858.CD011265.pub2). Popa 2019 (doi:10.37358/RC.19.9.7498). Didangelos T, et al. Nutrients 2024 (doi:10.3390/nu16183045). Smith AG, et al. Diabetes Care 2006 (doi:10.2337/dc05-2062).

About the Author

Dr. Michael Fitzmaurice, MD is a fellowship-trained peripheral nerve surgeon with a background in nerve physiology, metabolic health, and applied exercise physiology. Through years of surgical practice, during which he performed more than 3,000 peripheral nerve procedures, he observed the close relationship between metabolic health, cellular energy production, and nervous system function. His work focuses on how physical activity, recovery biology, and nutrition-informed strategies relate to long-term nerve and metabolic health.

He oversees Dr. Fitz Nutrition, an education-first initiative translating evidence-informed research into thoughtfully designed formulations for nerve and metabolic health, and believes that patients who understand the science make better decisions about their care.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

This content is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Individual results vary. Always consult a qualified healthcare provider regarding your individual medical situation. Product, price and label information reflects publicly available labels, brand pages and retailer listings as of October 26, 2026, and may change; check the current label before purchasing. Nerve Renew is a registered trademark of its owner. This article is independent and was not sponsored or approved by the brand. Dr. Fitzmaurice formulated, and has a financial interest in, NeuroAxis, and is the author of both studies on its predecessor formula.